Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Methicillin-resistant Staphylococcus aureus Stories

2013-09-25 08:30:16

CHICAGO, Sept. 25, 2013 /PRNewswire-USNewswire/ -- MRSA Survivors unite on September 28, 2013 for the 5(th) Annual World MRSA Day Kickoff event and Global C. diff Summit. The event will educate the public on how to help prevent MRSA and C. diff infections in healthcare facilities and in the community. The annual event is organized by MRSA Survivors Network, a Chicago-based nonprofit and global leader that raises awareness and educates the public concerning the MRSA epidemic and...

2013-09-23 23:04:13

MRSA is a serious skin infection that is becoming increasingly prevalent, particularly among athletes – from pint-sized wrestlers to professional football players. Vigilant skin hygiene is crucial to preventing skin infections. Medical experts recommend use of an effective cleanser like CLn SportWash or CLn BodyWash products that are non-drying and preserved with sodium hypochlorite. Dallas, Texas (PRWEB) September 23, 2013 In recent months, published reports on August 23 and September...

2013-09-17 23:32:27

UCL is the research partner of Ondine Biomedical Inc., the global leader in developing Photodisinfection (aPDT) based technologies and applications. Ondine is focused on Health Care Associated Infection (HAI) prevention products as well as therapies such as the MRSAid Photodisinfection System. (PRWEB) September 17, 2013 Ondine is pleased to announce that Sacha Noimark, Elaine Allan and Ivan Parkin were presented with the ‘Best Poster’ recognition at the EuCheMS Inorganic Chemistry...

2013-09-10 08:29:55

- Novel Locilex(TM) Formulation Demonstrates Favorable Stability at 18 Month Testing NEW YORK, Sept. 10, 2013 /PRNewswire/ -- Dipexium Pharmaceuticals, LLC today announced modifications made to the Locilex(TM) (pexiganan acetate cream 1%) formulation have resulted in favorable chemical and physical stability as noted in 18-month stability testing by its manufacturer. Stability Trend Analyses at 18 months suggest a Locilex(TM) shelf-life of at least 36 months at room temperature....

2013-09-05 23:25:45

MRSAid™ was recently featured in the 2013 ICPIC (International Consortium for Prevention & Infection Control) Innovation Award received by the Vancouver General Hospital infection control team lead by Dr. Elizabeth Bryce. The VGH team was the winner of this prestigious global recognition for pioneering a novel universal decolonization protocol involving Ondine’s Photodisinfection technology, MRSAid. Vancouver, British Columbia (PRWEB) September 05, 2013 Ondine Biomedical Inc. is...

2013-09-05 12:27:30

The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) research report by Kalorama Information is now available through RnRMarketResearch.com. DALLAS, Sept. 5, 2013 /PRNewswire-iReach/ -- This report focuses on preventing, testing and treating hospital-acquired infections in the healthcare environment. The major consideration is given to bacterial nosocomial infections because a) they are the most frequent type of infections spread in...

2013-09-04 12:33:11

Novel Anti-Infective Agent Leading to New Clinical Program for XBiotech AUSTIN, Texas, Sept. 4, 2013 /PRNewswire/ -- XBiotech announced today that it has completed discovery and has begun pre-clinical development of a new True Human(TM) antibody therapy for methicillin resistant staphylococcus aureus (MRSA). The new antibody therapy is expected to be effective at neutralizing drug resistant staphylococcus infection by circumventing key immune evasion strategies of the bacteria,...

2013-08-28 16:24:09

SPENCER, Iowa, Aug. 28, 2013 /PRNewswire/ -- Spencer Hospital today announced it is the first and only hospital in Iowa to implement Xenex Disinfection Services' UV room disinfection system in its patient and operating rooms. A "green," mercury-free technology, the Xenex system is the fastest, safest and most effective method for the advanced cleaning of hospital rooms, scientifically proven to destroy all major classes of microorganisms that cause hospital acquired infections...

2013-08-27 08:26:52

--Clinically-Proven Approach Integrates Three Technologies to Transform Scrub Uniforms into Medical Devices Providing Active Barrier Protection from Dangerous Contaminants-- ORLANDO, Fla., Aug. 27, 2013 /PRNewswire/ -- Vestagen Technical Textiles, Inc., today announced completion of an $8.25 million financing. Vestagen markets Vestex(®), the first in a new class of medical devices based on active barrier protective fabrics that are clinically proven to prevent or reduce the...

2013-08-14 08:30:27

BOSTON, Aug. 14, 2013 /PRNewswire/ -- Pathogenica, Inc. (www.pathogenica.com) announced today that the company has achieved the CE mark under the European Directive on In Vitro Diagnostic Medical Devices for its HAI BioDetection kit that runs on the Ion PGM(TM) benchtop sequencer. This milestone marks the HAI BioDetection CE-IVD kit as the first sequence-based infectious disease diagnostic kit on the market. "The kit and interpretation software system provides clinicians with a...